Reported by New York Times — Business •
15 Public broadcaster provisional

Growth of Genetic Risk Scoring and Implications for Anti-Discrimination Laws

The use of polygenic risk scoring in personal medicine is on the rise, prompting discussions about the effectiveness of anti-discrimination laws regarding genetic data. As this technology advances, the legal protections for individuals' genetic information may need to be reevaluated.

Our neutral summary

The use of polygenic risk scoring in personal medicine is on the rise, prompting discussions about the effectiveness of anti-discrimination laws regarding genetic data. As this technology advances, the legal protections for individuals' genetic information may need to be reevaluated.

Read the full story at New York Times — Business

The reporting belongs to New York Times — Business; we don't reproduce it.

Annotating as

No note attached

on this article.

Original vs. Neutral

Original Headline

Genetic Scores are Booming. But Will Anti-Discrimination Laws Cover Your DNA?

Neutral Headline

Growth of Genetic Risk Scoring and Implications for Anti-Discrimination Laws